Approval · Notice of Compliance 7585 · 2005
CO AZITHROMYCIN: Notice of Compliance 7585
Issued November 1, 2005
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 7585
- Date
- November 1, 2005
- Company
- Cobalt Pharmaceuticals IncorporatedToronto, Ontario, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Abbreviated New Drug Submission (ANDS)
- Submission class
- Other
- Therapeutic class
- Antibiotic
- Canadian reference product
- ZITHROMAX (Pfizer Canada Ulc)
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| CO AZITHROMYCIN | 02255340 | Cancelled Post Market |
Medicinal ingredients
- AZITHROMYCIN MONOHYDRATE 250 MG per TAB